Seres Therapeutics, Inc.MCRBNASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank92
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
23.14
↓ 75% vs avg
Percentile
P92
Near historical high
Streak
1 yr
Consecutive declineCompressed
Average
92.16
Historical baseline
PeriodValueYoY Change
202523.14-97.6%
2024949.54+60358.5%
2023-1.58+34.9%
2022-2.42+79.2%
2021-11.65+46.9%
2020-21.93-688.7%
2019-2.78-49.4%
2018-1.86+59.4%
2017-4.59-6.5%
2016-4.31-